SCHEMBL6741709

SCHEMBL6741709

CC(C)C(CN)NC(C)(C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.42
SLC6A3 Q01959 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
CACNA1F O60840 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
OPRK1 P41145 1/20 0.36
CACNA1D Q01668 1/20 0.36
KCNH2 Q12809 1/20 0.36
CACNA1S Q13698 1/20 0.36
CACNA1C Q13936 1/20 0.36
SCN5A Q14524 1/20 0.36
KIF11 P52732 2/20 0.35
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5402653 0.74 TDP1 (0.46) TAAR1SLC6A3SLC6A4CACNA1FCHRM2
SCHEMBL24453542 0.72 CACNA1F (0.43) TAAR1SLC6A3CACNA1FCHRM2CHRM1
SCHEMBL6226291 0.69 CHRM2 (0.44) SLC6A3SLC6A2SLC6A4CACNA1FCHRM2
SCHEMBL6248389 0.69 SIGMAR1 (0.55) TAAR1CYP1A2CYP3A4CYP2D6
SCHEMBL6741704 0.68 BACE1 (0.39) TAAR1SLC6A3SLC6A2SLC6A4KIF11
SCHEMBL19361268 0.68 MAPT (0.48) CHRM2CHRM1CHRM3KCNH2KIF11
SCHEMBL3640366 0.67 TAAR1 (0.50) TAAR1SLC6A3SLC6A2SLC6A4CACNA1F
SCHEMBL5969931 0.67 HDAC3 (0.44) KIF11CYP1A2KCNN4CYP2D6
Hydrochloric Acid SCHEMBL9796807 0.67 KCNN4 (0.36) TAAR1SLC6A3CACNA1FCHRM2CHRM1
SCHEMBL20357562 0.66 KIF11 (0.64) TAAR1KIF11KCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229838-A1 Purine derivatives PFIZER INC 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229838-A1 Purine derivatives ADORA2A, ADORA1, ADORA3 TAAR1 92/4885SLC6A3 515/4885SLC6A2 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.